Morganti-Kossmann MC - Search Results

1

Neurotransmitters in cerebrospinal fluid reflect pathological activity.

Stover JF, Pleines UE, Morganti-Kossmann MC, Kossmann T, Lowitzsch K, Kempski OS. Stover JF, et al. Eur J Clin Invest. 1997 Dec;27(12):1038-43. doi: 10.1046/j.1365-2362.1997.2250774.x. Eur J Clin Invest. 1997. PMID: 9466133

2

Thiopental and midazolam do not seem to impede metabolism of glutamate in brain-injured patients.

Stover JF, Pleines UE, Morganti-Kossmann MC, Stocker R, Kempski OS, Kossmann T. Stover JF, et al. Psychopharmacology (Berl). 1999 Jan;141(1):66-70. doi: 10.1007/s002130050807. Psychopharmacology (Berl). 1999. PMID: 9952066 Clinical Trial.

3

Thiopental attenuates energetic impairment but fails to normalize cerebrospinal fluid glutamate in brain-injured patients.

Stover JF, Pleines UE, Morganti-Kossmann MC, Stocker R, Kossmann T. Stover JF, et al. Crit Care Med. 1999 Jul;27(7):1351-7. doi: 10.1097/00003246-199907000-00028. Crit Care Med. 1999. PMID: 10446831 Clinical Trial.

4

Penetration of cefuroxime into the cerebrospinal fluid of patients with traumatic brain injury.

Kossmann T, Hans V, Stocker R, Imhof HG, Joos B, Trentz O, Morganti-Kossmann MC. Kossmann T, et al. J Antimicrob Chemother. 1996 Jan;37(1):161-7. doi: 10.1093/jac/37.1.161. J Antimicrob Chemother. 1996. PMID: 8647759 Free article.

5

Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injury.

Kossmann T, Stahel PF, Morganti-Kossmann MC, Jones JL, Barnum SR. Kossmann T, et al. J Neuroimmunol. 1997 Mar;73(1-2):63-9. doi: 10.1016/s0165-5728(96)00164-6. J Neuroimmunol. 1997. PMID: 9058760

6

Soluble ICAM-1 in CSF coincides with the extent of cerebral damage in patients with severe traumatic brain injury.

Pleines UE, Stover JF, Kossmann T, Trentz O, Morganti-Kossmann MC. Pleines UE, et al. J Neurotrauma. 1998 Jun;15(6):399-409. doi: 10.1089/neu.1998.15.399. J Neurotrauma. 1998. PMID: 9624625 Free article.

7

Thiopental in CSF and serum correlates with prolonged loss of cortical activity.

Stover JF, Lenzlinger PM, Stocker R, Morganti-Kossmann MC, Imhof HG, Trentz O, Kossmann T. Stover JF, et al. Eur Neurol. 1998;39(4):223-8. doi: 10.1159/000007938. Eur Neurol. 1998. PMID: 9635473 Free article. Clinical Trial.

8

Increased interleukin-12 levels in human cerebrospinal fluid following severe head trauma.

Stahel PF, Kossmann T, Joller H, Trentz O, Morganti-Kossmann MC. Stahel PF, et al. Neurosci Lett. 1998 Jun 19;249(2-3):123-6. doi: 10.1016/s0304-3940(98)00410-8. Neurosci Lett. 1998. PMID: 9682832

9

Interleukin-6 and its soluble receptor in serum and cerebrospinal fluid after cerebral trauma.

Hans VH, Kossmann T, Joller H, Otto V, Morganti-Kossmann MC. Hans VH, et al. Neuroreport. 1999 Feb 5;10(2):409-12. doi: 10.1097/00001756-199902050-00036. Neuroreport. 1999. PMID: 10203344

10

IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function.

Csuka E, Morganti-Kossmann MC, Lenzlinger PM, Joller H, Trentz O, Kossmann T. Csuka E, et al. J Neuroimmunol. 1999 Nov 15;101(2):211-21. doi: 10.1016/s0165-5728(99)00148-4. J Neuroimmunol. 1999. PMID: 10580806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters